No Differences in Gastrointestinal Bleeding Risk among Clopidogrel-, Ticagrelor-, or Prasugrel-Based Dual Antiplatelet Therapy

The risk for gastrointestinal bleeding from dual antiplatelet therapy (DAPT) with new antiplatelets (prasugrel/ticagrelor) compared to clopidogrel is unclear. Aim: To determine the risk and type of major (gastrointestinal bleeding requiring hospitalization) and minor (anemia and iron deficiency) gas...

Descripción completa

Detalles Bibliográficos
Autores principales: Laredo, Viviana, Sostres, Carlos, García, Sandra, Carrera-Lasfuentes, Patricia, Revilla-Marti, Pablo, Lanas, Ángel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7290690/
https://www.ncbi.nlm.nih.gov/pubmed/32443621
http://dx.doi.org/10.3390/jcm9051526

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7290690/
https://www.ncbi.nlm.nih.gov/pubmed/32443621
http://dx.doi.org/10.3390/jcm9051526

Ejemplares similares